Bioethics, FDA and Licensing - Health Care Compliance Brief

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Bioethics

FDA

Licensing

What You Need to Know About Marijuana Rescheduling

Bill of Health

MAY 28, 2024

Schedule 3 drugs must be approved by the Food and Drug Administration (FDA,) prescribed by a doctor, and distributed by a pharmacy. Congress must specify that FDA’s jurisdiction over cannabis should be no more than that over alcohol and designate cannabis in food as “generally recognized as safe.” Victoria Litman M.Div, J.D.,

FDA

FDA Bioethics Compliance Telemedicine

Q&A: George Church on Genomics of Cognitive Enhancement

Bill of Health

JUNE 12, 2024

In these spin-offs, does one approach the Church Lab with a request for licensing or are there collaboration agreements with the Harvard Office of Technology Review? The practicality I’ve noticed over the years is that no matter what we aim at, there’s the very severe, shorter-term FDA trial. GC: Both are possible.

FDA

FDA Licensing Bioethics

Reasonable Pricing Clauses: A First Step Toward Ensuring Taxpayers a Fair Return on their Public R&D Investment

Bill of Health

SEPTEMBER 28, 2023

In the initial discussion draft of the Pandemic and All-Hazards Preparedness Act (PAHPA), Senator Sanders proposed similar reasonable pricing clauses.

COVID-19

COVID-19 COVID-19 Vaccine Pharmaceutical Industry Governance

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

What You Need to Know About Marijuana Rescheduling

Q&A: George Church on Genomics of Cognitive Enhancement

Reasonable Pricing Clauses: A First Step Toward Ensuring Taxpayers a Fair Return on their Public R&D Investment

Webinars

Stay Connected